The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism
Open accessAbstract
The major pathological features of Alzheimer’s disease (AD) include amyloid plaques composed primarily of the β-amyloid (Aβ) peptide, degenerating neurons and neurofibrillary tangles, and the presence of numerous activated astrocytes and microglia. Although extensive genetic data implicate Aβ in the neurodegenerative cascade of AD, the molecular mechanisms underlying its effects on neurons and glia and the relationship between glial activation and neuronal death are not well defined. Aβ has been shown to induce glial activation, and a growing body of evidence suggests that activated glia contribute to neurotoxicity through generation of inflammatory cytokines and neurotoxic free radicals, such as nitric oxide (NO), potent sources of oxidative stress known to occur in AD. It is therefore crucial to identify specific Aβ-induced molecular pathways mediating these responses in activated glia. We report that Aβ stimulates the activation of the transcription factor NFκB in rat astrocytes, that NFκB activation occurs selectively from p65 transactivation domain 2, and that Aβ-induced NO synthase expression and NO production occur through an NFκB-dependent mechanism. This demonstration of how Aβ couples an intracellular signal transduction pathway involving NFκB to a potentially neurotoxic response provides a key mechanistic link between Aβ and the generation of oxidative damage. Our results also suggest possible molecular targets upon which to focus future drug discovery efforts for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,312
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
NF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
NF-kB: a crucial transcription factor for glial and neuronal cell function
O'Neill, L. A. J., & Kaltschmidt, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01035-1 · Cited by 1,013
Coupling of a Signal Response Domain in IκBα to Multiple Pathways for NF-κB Activation
Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi, X., Lee, W. Y., & Ballard, D. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2809 · Cited by 684
Barger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 631
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., & Kaltschmidt, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2642 · Cited by 616
Glial cytokines in Alzheimer's disease: Review and pathogenic implications
Mrak, R. E., Sheng, J. G., & Griffin, W. S. T. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90001-2 · Cited by 418
de Vera, M. E., Shapiro, R. A., Nussler, A. K., Mudgett, J. S., Simmons, R. L., Morris, S. M., Billiar, T. R., & Geller, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1054 · Cited by 399
Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D., & Games, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-18-05795.1996 · Cited by 370
Seipel, K., Georgiev, O., & Schaffner, W. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05603.x · Cited by 349
THE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
Breitner, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.401 · Cited by 263
Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., & Van Eldik, L. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01318-8 · Cited by 262
Self-citationFujita, T., Shibuyà, H., Hotta, H., Yamanishi, K., & Taniguchi, T. (1987) · Cell · doi:10.1016/0092-8674(87)90288-1 · Cited by 215
Induction of cyclin D1 by simian virus 40 small tumor antigen
Watanabe, G., Howe, A., Lee, R. J., Albanese, C., Shu, I.-W., Karnezis, A. N., Zon, L., Kyriakis, J., Rundell, K., & Pestell, R. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12861 · Cited by 210
Self-citationS100β Stimulates Inducible Nitric Oxide Synthase Activity and mRNA Levels in Rat Cortical Astrocytes
Hu, J., Castets, F., Guevara, J. L., & Van Eldik, L. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2543 · Cited by 173
Self-citationβ-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity
Ii, M., Sunamoto, M., Ohnishi, K., & Ichimori, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00156-4 · Cited by 166
Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ
Goodwin, J. L., Uemura, E., & Cunnick, J. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00646-8 · Cited by 165
Transactivation Domain 2 (TA2) of p65 NF-κB
Schmitz, M. L., Silva, M. A. D. S., & Baeuerle, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15576 · Cited by 158
Nitric Oxide Synthase in Reactive Astrocytes Adjacent to β-Amyloid Plaques
Wallace, M. N., Geddes, J. G., Farquhar, D. A., & Masson, M. R. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6373 · Cited by 145
Synergistic Induction of Nitric Oxide by β-Amyloid and Cytokines in Astrocytes
Rossi, F., & Bianchini, E. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1197 · Cited by 133
Hensley, K., BUTTERFIELDLD, D. A., Hall, N. C., COLE, P., Subramaniam, R., Mark, R. J., Mattson, M. P., Markesbery, W. R., Harris‐White, M. E., Aksenov, M. Y., et al. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39057.x · Cited by 117
Enhancement of immunoreactivity for NF-κB in human cerebral infarctions
Terai, K., Matsuo, A., McGeer, E. G., & McGeer, P. L. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01073-6 · Cited by 86
Dyke, K. V. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90031-1 · Cited by 49
Sue, W.-C., Griffin, T. W., & Stanley, L. C. (1993) · Springer eBooks · doi:10.1007/978-1-4757-9486-1_32 · Cited by 13
Cited by
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853
NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review
Shih, R.-H., Wang, C.-Y., & Yang, C.-M. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00077 · Cited by 910
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Metadata
- Authors
- Akama, K. T., Albanese, C., Pestell, R. G., & Van Eldik, L. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-05-12
- Volume
- 95
- Issue
- 10
- Pages
- 5795-5800
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2085278496
- Cited by
- 349
- References
- 33
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.